Respirology
Guaifenesin Non-prescription in Your Practice (2022)
Guaifenesin is a mucoactive agent that provides symptomatic management of chest congestion and cough associated with acute upper respiratory tract infections (URTIs). This accredited program reviews the purpose of mucus in a healthy respiratory system, and what happens when hypersecretion or mucus dysfunction occurs. Guaifenesin increases hydration of airway mucus, increases the volume of bronchial secretions and decreases mucus viscosity, which enhances clearance by promoting more effective expectoration.
Two case studies highlight key features of guaifenesin including indications, dosing and frequency. The impact of COVID-19 on counseling customers with respiratory symptoms is also addressed.
DURATION
30 min
PROFESSION
Pharmacy
# OF CREDITS
1.25
ACCREDITATION
CCCEP
EXPIRY DATE
2024-01-25
Guaifenesin is a mucoactive agent that provides symptomatic management of chest congestion and cough associated with acute upper respiratory tract infections (URTIs). This accredited program reviews the purpose of mucus in a healthy respiratory system, and what happens when hypersecretion or mucus dysfunction occurs. Guaifenesin increases hydration of airway mucus, increases the volume of bronchial secretions and decreases mucus viscosity, which enhances clearance by promoting more effective expectoration.
Two case studies highlight key features of guaifenesin including indications, dosing and frequency. The impact of COVID-19 on counseling customers with respiratory symptoms is also addressed.
This program has received an unrestricted educational grant or in-kind support from Mead Johnson Nutrition.
Faculty
Carole Dion, BSc Pharm
Kelly Haggerty, BSc Pharm, RPh, NCMP, ISTM, CTH
Ali Reza Ladak, Bsc Pharm, RPh
Learning objectives
Upon completion of this continuing education program, participants will be better able to:
- Describe how guaifenesin works as a mucoactive agent to relieve congestion associated with common colds and upper respiratory tract infections;
- Identify the approved indications for guaifenesin and supporting data;
- Determine the dosage best suited for individuals experiencing cough and congestion from the common cold and flu;
- Discuss the use of multi-symptom products for temporary relief from chest, nasal and sinus congestion, headache, sore throat, and minor aches and pains.
Accreditation
This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 1.25 CEUs.
CCCEP File Number: 1066-2022-3550-I-P.